Date:2/20/2013

ney failure and renal disease.  Together with its physician partners, DSI Renal owns and operates 88 dialysis clinics in 23 states.  The company plans for growth through acquisition and development of new clinics as well as through establishment of additional joint venture partnerships with leading nephrologists for the clinic, hospital and alternate settings.  For more information, please visit www.dsi-corp.com.

Clinic Contact:
DSI New Smyrna Beach Dialysis
Tonya Phillips , R.N. - Clinic Manager
(386) 409-8855
tophillips@dsi-corp.com

Corporate Contact:
Giles Ward
DSI Renal
(615) 777-8200
gward@dsi-corp.com

Media Contact:
Angela Novak
Corner Office Communications
(615) 406-0715
anovak@cornerofficecommunication.com

'/>"/>

SOURCE DSI Renal Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. PLC to Demonstrate RenalGuard® at EuroPCR 2012
3. Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis
4. Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
5. The International Serious Adverse Event Consortium and UC San Diego To Collaborate On Research Into The Genetics Of Drug Induced Renal Injury
6. Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
7. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
8. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
9. PLZ Aeroscience Acquires Assured Packaging
10. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
11. PneumRx, Inc. Acquires Key Assets From Broncus